HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (2- methyl- 5- (9- oxa- 3,7- diazabicyclo(3.3.1)non- 3- ylcarbonyl)phenyl)- 2- tricyclo(3.3.1.13,7)dec- 1- ylacetamide

a P2X7 receptor antagonist; structure in first source

Also Known As:

N-MODNCP-TDAcNH2

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Adamantane: 182
        N-(2-methyl-5-(9-oxa-3,7-diazabicyclo(3.3.1)non-3-ylcarbonyl)phenyl)-2-tricyclo(3.3.1.13,7)dec-1-ylacetamide
    - Bridged-Ring Compounds: 1
      - Adamantane: 182
        N-(2-methyl-5-(9-oxa-3,7-diazabicyclo(3.3.1)non-3-ylcarbonyl)phenyl)-2-tricyclo(3.3.1.13,7)dec-1-ylacetamide
- Aza Compounds: 3
  - Azabicyclo Compounds
    - N-(2-methyl-5-(9-oxa-3,7-diazabicyclo(3.3.1)non-3-ylcarbonyl)phenyl)-2-tricyclo(3.3.1.13,7)dec-1-ylacetamide
Heterocyclic Compounds: 198
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - Azabicyclo Compounds
      - N-(2-methyl-5-(9-oxa-3,7-diazabicyclo(3.3.1)non-3-ylcarbonyl)phenyl)-2-tricyclo(3.3.1.13,7)dec-1-ylacetamide